Page last updated: 2024-11-01

ondansetron and Intradural-Extramedullary Spinal Cord Neoplasms

ondansetron has been researched along with Intradural-Extramedullary Spinal Cord Neoplasms in 1 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wong, ET1
Portlock, CS1
O'Brien, JP1
DeAngelis, LM1

Trials

1 trial available for ondansetron and Intradural-Extramedullary Spinal Cord Neoplasms

ArticleYear
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma.
    Neurology, 1996, Volume: 46, Issue:6

    Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dox

1996